Figures computed from official regulatory filings — .
Enough buys on record, but none of them has a 63-day return yet — this happens when the shares stopped trading, or when the buys are too recent. Win rates will appear once returns mature.
This page republishes public regulatory disclosures.
| Company | Type | Value · USD | Signals | Details | |
|---|---|---|---|---|---|
Celator Pharmaceuticals IncListing unverified | Other | $4.4M | SEC | ||
Celator Pharmaceuticals IncListing unverified | Other | $31.4M | SEC | ||
Celator Pharmaceuticals IncListing unverified | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC | ||
Celator Pharmaceuticals IncListing unverified | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC | ||
Celator Pharmaceuticals IncListing unverified | Buy | $3.3K | conv 5 | SEC | |
Celator Pharmaceuticals IncListing unverified | Buy | $334 | conv 18First in 12mo | SEC | |
Celator Pharmaceuticals IncListing unverified | Buy | $3.4K | conv 19First in 12mo | SEC | |
Celator Pharmaceuticals IncListing unverified | Buy | $5K | conv 19First in 12mo | SEC | |
Celator Pharmaceuticals IncListing unverified | Buy | $8.1K | conv 20First in 12mo | SEC |